Steqeyma 45 MG per 0.5 ML Injection

RxCUI: 2740800
RxNorm name: Steqeyma 45 MG per 0.5 ML Injection
Display name: Steqeyma 45 MG per 0.5 ML Injection
Full name: Steqeyma 45 MG per 0.5 ML Injection
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:01

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761338	Steqeyma	ustekinumab-stba	351(k) Interchangeable	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
STEQEYMA	USTEKINUMAB-STBA	CELLTRION USA, Inc.	66085e17-e3f2-4196-8c81-87448e804b0c	2026-04-07	Warnings, Adverse reactions	Exact identifier rxcui: 2740800

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
66085e17-e3f2-4196-8c81-87448e804b0c	Steqeyma 45 MG per 0.5 ML Injection	SY	12	These highlights do not include all the information needed to use STEQEYMA safely and effectively. See full prescribing information for STEQEYMA. STEQEYMA (ustekinumab-stba) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2024 STEQEYMA (ustekinumab-stba) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningf	20260407
66085e17-e3f2-4196-8c81-87448e804b0c	SteQeyma 45 MG in 0.5 ML Injection	PSN	12	These highlights do not include all the information needed to use STEQEYMA safely and effectively. See full prescribing information for STEQEYMA. STEQEYMA (ustekinumab-stba) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2024 STEQEYMA (ustekinumab-stba) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningf	20260407
66085e17-e3f2-4196-8c81-87448e804b0c	0.5 ML ustekinumab-stba 90 MG/ML Injection [Steqeyma]	SBD	12	These highlights do not include all the information needed to use STEQEYMA safely and effectively. See full prescribing information for STEQEYMA. STEQEYMA (ustekinumab-stba) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2024 STEQEYMA (ustekinumab-stba) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningf	20260407